Characteristics of Patients With Recessive Dystrophic Epidermolysis Bullosa (NCT01019148)
🩺 Plain-English Summary (8th-Grade Level)
Recessive dystrophic epidermolysis bullosa (RDEB) is a disease caused by genetic mutations in the gene for type VII collagen. Patients with RDEB develop large, severely painful blisters and open wounds from minor trauma to their skin. We are screening subjects with RDEB to evaluate characteristics of the subjects and their cells in order to develop new strategies of therapy and determine whether subjects could be candidates for treatment studies.
Who can join: Review the eligibility criteria below.
Location: Stanford University School of Medicine — Stanford, California
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Stanford University School of Medicine — Stanford, California
📞 Contact the Study Coordinator
Phone: (650) 721-7149
Email: baileyhi@stanford.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Epidermolysis Bullosa Dystrophica
- Artificial Intelligence Patient App for RDEB SCCs — Chicago, Illinois
- Self-Assembled Skin Substitute for the Treatment of Epidermolysis Bullosa — Toronto, Ontario
- A Natural History Study of Corneal Abrasions in Patients With Dystrophic Epidermolysis Bullosa (DEB) — Pittsburgh, Pennsylvania
Explore by condition: All Epidermolysis Bullosa Dystrophica clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.